Hepatic steatosis in cardiovascular–kidney–metabolic syndrome: fatty liver Index as a predictor of cardiovascular outcomes
The FLI is an independent prognostic marker for cardiovascular outcomes across the CKM syndrome spectrum. Incorporating FLI into clinical practice could enhance early risk stratification and inform timely interventions, especially in patients at early stages of CKM syndrome, thereby potentially improving long-term cardiometabolic and renal outcomes.
Authors
- Byung Sik Kim (ORCID: https://orcid.org/0000-0002-7813-4733)
- Hasung Kim (ORCID: https://orcid.org/0000-0002-2519-6244)
- Jeong‐Hun Shin (ORCID: https://orcid.org/0000-0002-6718-9763)
- Jungkuk Lee (ORCID: https://orcid.org/0000-0003-1874-449X)
- Hyun‐Jin Kim (ORCID: https://orcid.org/0000-0002-7885-1695)
- Sang Bong Ahn
- Young Hyo Lim
Institutions
- Eulji University (KR)
- Hanmi Pharmaceutical (South Korea) (KR)
- Hanyang University (KR)
- Anyang University (KR)
Publication Details
- Journal
- European Journal of Preventive Cardiology
- Published
- 2025-06-30
- DOI
- https://doi.org/10.1093/eurjpc/zwaf396
- Citations
- 5
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 6.77